NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Viking Therapeutics Inc (NASDAQ: VKTX)

 
VKTX Technical Analysis
5
As on 1st Aug 2025 VKTX SHARE Price closed @ 32.68 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 59.87 & Strong Sell for SHORT-TERM with Stoploss of 67.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VKTXSHARE Price

Open 32.00 Change Price %
High 33.57 1 Day 0.11 0.34
Low 31.80 1 Week -0.72 -2.16
Close 32.68 1 Month 6.40 24.35
Volume 3342671 1 Year 0.45 1.40
52 Week High 94.50 | 52 Week Low 19.98
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 173.72 -2.33%
OPEN 2.10 14.13%
EQ 0.71 82.05%
AMZN 214.75 -8.27%
NCNA 0.04 0.00%
LMDX 0.02 0.00%
BTAI 1.37 4.58%
AKTS 0.04 0.00%
AAPL 202.38 -2.50%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
HCTI 4.75 15733.33%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
ORGS 1.00 1566.67%
REDU 3.41 1075.86%
DRMA 6.45 940.32%
CTXRW 0.14 600.00%
NBSTU 12.99 220.74%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
OTRKP 0.02 -60.00%
HEPA 0.05 -58.33%
 
 
VKTX
Daily Charts
VKTX
Intraday Charts
Whats New @
Bazaartrend
VKTX
Free Analysis
 
VKTX Important Levels Intraday
RESISTANCE36.09
RESISTANCE35.00
RESISTANCE34.32
RESISTANCE33.64
SUPPORT31.72
SUPPORT31.04
SUPPORT30.36
SUPPORT29.27
 
VKTX Forecast August 2025
4th UP Forecast164.58
3rd UP Forecast122.28
2nd UP Forecast96.13
1st UP Forecast69.99
1st DOWN Forecast-4.63
2nd DOWN Forecast-30.77
3rd DOWN Forecast-56.92
4th DOWN Forecast-99.22
 
VKTX Weekly Forecast
4th UP Forecast156.80
3rd UP Forecast116.99
2nd UP Forecast92.39
1st UP Forecast67.78
1st DOWN Forecast-2.42
2nd DOWN Forecast-27.03
3rd DOWN Forecast-51.63
4th DOWN Forecast-91.44
 
VKTX Forecast2025
4th UP Forecast187.78
3rd UP Forecast138.04
2nd UP Forecast107.29
1st UP Forecast76.55
1st DOWN Forecast-11.19
2nd DOWN Forecast-41.93
3rd DOWN Forecast-72.68
4th DOWN Forecast-122.42
 
 
VKTX Other Details
Segment EQ
Market Capital 466793088.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VKTX Address
VKTX
 
VKTX Latest News
 
Your Comments and Response on Viking Therapeutics Inc
 
VKTX Business Profile
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. Viking Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California. Address: 12340 El Camino Real, San Diego, CA, United States, 92130
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service